IP Library Granted Patent US 8,673,580
Granted Patent B2
US 8,673,580 · App. 12/990,047 · Granted Mar 18, 2014

Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation

Inventors: Katsuto Tamai (Osaka, JP); Takehiko Yamazaki (Osaka, JP); Takenao Chino (Osaka, JP); Yasufumi Kaneda (Osaka, JP)
Assignees: Genomix Co., Ltd.; Osaka University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,673,580
App. No.
12/990,047
Granted
Mar 18, 2014
Kind
B2
Abstract

The present invention for the first time demonstrated that: (1) bone marrow-derived pluripotent tissue stem cells can be induced in peripheral blood by intravenously administering tissue extract prepared from isolated skin pieces; (2) the substance in the isolated skin pieces, which is responsible for mobilizing bone marrow-derived pluripotent tissue stem cells to peripheral blood, is HMGB1; and (3) HMGB1 with the activity of mobilizing bone marrow-derived pluripotent stem cells to peripheral blood can be easily purified from cultured cells.

Claims (16)

1. A method of mobilizing a bone marrow mesenchymal stem cell to peripheral blood from bone marrow, comprising the steps of administering to blood vessel or muscle of a living animal one or more substances selected from the group consisting of:

(a) an HMGB1 protein;

(b) a cell that secretes an HMGB1 protein;

(c) a vector inserted with a DNA encoding an HMGB1 protein;

(d) an HMGB2 protein;

(e) a cell that secretes an HMGB2 protein;

(f) a vector inserted with a DNA encoding HMGB2 protein;

(g) an HMGB3 protein;

(h) a cell that secretes an HMGB3 protein; and

(i) a vector inserted with a DNA encoding an HMGB3 protein; and mobilizing a bone marrow mesenchymal stem cell to peripheral blood from bone marrow.

2. The method according to claim 1 , wherein one or more substances selected from (a) to (i) are administered to blood vessel.

3. The method according to claim 2 , wherein one or more substances selected from (a) to (i) are administered via intravascular injection.

4. The method according to claim 3 , wherein one or more substances selected from (a) to (i) are administered via intraarterial injection or intravenous injection.

5. The method according to claim 1 , wherein one or more substances selected from (b) to (i) are administered.

6. The method according to claim 1 , wherein one or more substances from (d) to (i) are administered.

7. The method according to claim 1 , wherein the living animal is human.

Assignments (3)
CHANGE OF NAME Recorded Sep 18, 2018
From: GENOMIX CO., LTD.
To: STEMRIM INC.
Reel/Frame 047102/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2011
From: YAMAZAKI, TAKEHIKO; CHINO, TAKENAO
To: GENOMIX CO., LTD.
Reel/Frame 025630/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2011
From: TAMAI, KATSUTO; KANEDA, YASUFUMI
To: OSAKA UNIVERSITY
Reel/Frame 025632/0373 →
Priority Claims (1)
JP 2008-119348 · Apr 30, 2008 · national
Continuity (1)
Related Publication 20110091928A1 · Apr 21, 2011